Avrin Pharma Ltd 09866322 false 2024-12-01 2025-11-30 2025-11-30 The principal activity of the company is Pharmaceutical consultancy Digita Accounts Production Advanced 6.30.9574.0 true 09866322 2024-12-01 2025-11-30 09866322 2025-11-30 09866322 core:CurrentFinancialInstruments core:WithinOneYear 2025-11-30 09866322 core:Non-currentFinancialInstruments core:AfterOneYear 2025-11-30 09866322 bus:Micro-entities 2024-12-01 2025-11-30 09866322 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 09866322 bus:FilletedAccounts 2024-12-01 2025-11-30 09866322 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 09866322 bus:RegisteredOffice 2024-12-01 2025-11-30 09866322 bus:Director1 2024-12-01 2025-11-30 09866322 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 09866322 bus:Agent1 2024-12-01 2025-11-30 09866322 countries:England 2024-12-01 2025-11-30 09866322 2023-12-01 2024-11-30 09866322 2024-11-30 09866322 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-30 09866322 core:Non-currentFinancialInstruments core:AfterOneYear 2024-11-30 iso4217:GBP xbrli:pure

Registration number: 09866322

Avrin Pharma Ltd
Unaudited Filleted Financial Statements
for the Year Ended 30 November 2025

Avrin Pharma Ltd

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 2

Avrin Pharma Ltd

Company Information

Director | Mr EK Naderali

Registered office | 13 Walton Vale Liverpool Merseyside L9 4RE

Accountants | JBRS Accountants Limited 13 Walton Vale Liverpool Merseyside L9 4RE

Avrin Pharma Ltd

(Registration number: 09866322)
Balance Sheet as at 30 November 2025

| 2025 £ | 2024 £
Fixed assets | 20,189 | 16,046
Current assets | 4,058 | 9,264
Prepayments and accrued income | 8,800 | -
Creditors: Amounts falling due within one year | (1,404) | (1,887)
Net current assets | 11,454 | 7,377
Total assets less current liabilities | 31,643 | 23,423
Creditors: Amounts falling due after more than one year | (18,932) | (8,904)
Accruals and deferred income | (1,102) | (1,042)
| 11,609 | 13,477
Capital and reserves | 11,609 | 13,477

1 | General information

2 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2024 - 1).

For the financial year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 5 May 2026

......................................... Mr EK Naderali Director